Drug transport across the placenta, role of the ABC drug efflux transporters

被引:51
作者
Behravan, Javad [1 ,2 ]
Piquette-Miller, Micheline [1 ]
机构
[1] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON M5S 3M2, Canada
[2] Mashhad Univ Med Sci, Biotechnol Res Ctr, Fac Pharm, Mashhad, Iran
关键词
blood-placenta barrier; drug transporters; multi-drug resistance; placenta;
D O I
10.1517/17425255.3.6.819
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The placenta serves an important role both as a protective barrier as well as in normal fetal development. The ATP-binding cassette (ABC) proteins perform crucial functions in the distribution of nutrients and exchange of waste metabolites across the placenta. They also protect the developing fetus from xenobiotics to which the pregnant mother is exposed. Recent studies in P-glycoprotein (P-gp) deficient mdr1a and mdr1b (-/-) CF-1 mice have shown pronounced increases in fetal exposure to P-gp substrates due to increased transplacental penetration demonstrating the important protective role of P-gp to the developing fetus. The role of placental ABC transporter proteins in protecting the fetus against maternal exposure to drugs, toxins and other xenobiotics is discussed. Overall, the paucity of information available on the transplacental transfer of drugs emphasizes the need to further employ preclinical in vivo models for drug development in order to best predict fetal outcomes of drug administration to pregnant mothers.
引用
收藏
页码:819 / 830
页数:12
相关论文
共 132 条
  • [31] GADSBY JE, 1980, J REPROD FERTIL, V60, P409, DOI 10.1530/jrf.0.0600409
  • [32] Transport of glyburide by placental ABC transporters: Implications in fetal drug exposure
    Gedeon, C.
    Behravan, J.
    Koren, G.
    Piquette-Miller, M.
    [J]. PLACENTA, 2006, 27 (11-12) : 1096 - 1102
  • [33] Designing pregnancy centered medications: Drugs which do not cross the human placenta
    Gedeon, C.
    Koren, G.
    [J]. PLACENTA, 2006, 27 (08) : 861 - 868
  • [34] P-glycoprotein expression of the human placenta during pregnancy
    Gil, S
    Saura, R
    Forestier, F
    Farinotti, R
    [J]. PLACENTA, 2005, 26 (2-3) : 268 - 270
  • [35] Explaining interindividual variability of docetaxel pharmacokinetics and pharmacodynamics in Asians through phenotyping and genotyping strategies
    Goh, BC
    Lee, SC
    Wang, LZ
    Fan, L
    Guo, JY
    Lamba, J
    Schuetz, E
    Lim, R
    Lim, HL
    Ong, AB
    Lee, HS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3683 - 3690
  • [36] ISOLATION AND EXPRESSION OF A COMPLEMENTARY-DNA THAT CONFERS MULTIDRUG RESISTANCE
    GROS, P
    BEN-NERIAH, Y
    CROOP, JM
    HOUSMAN, DE
    [J]. NATURE, 1986, 323 (6090) : 728 - 731
  • [37] The MRP-related and BCRP/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation
    Haimeur, A
    Conseil, G
    Deeley, RG
    Cole, SPC
    [J]. CURRENT DRUG METABOLISM, 2004, 5 (01) : 21 - 53
  • [38] Dermatologic agents during pregnancy and lactation: an update and clinical review
    Hale, EK
    Pomeranz, MK
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2002, 41 (04) : 197 - 203
  • [39] PLACENTAL HISTOLOGY AND THE PRODUCTION OF HUMAN CHORIOGONADOTROPHIN AND ITS SUBUNITS IN PREGNANCY
    HAY, DL
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1988, 95 (12): : 1268 - 1275
  • [40] Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
    Heikkinen, T
    Ekblad, U
    Palo, P
    Laine, K
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (04) : 330 - 337